|
Volumn 111, Issue 2, 2014, Pages 212-213
|
Effect of rapid cessation of enzyme replacement therapy: A report of 5 more cases
|
Author keywords
Enzyme replacement therapy; Hunter syndrome; Maroteaux Lamy syndrome; Mucopolysaccharidosis type II; Mucopolysacchridosis type VI
|
Indexed keywords
GALSULFASE;
IDURONATE 2 SULFATASE;
CATAPLEXY;
COMPASSIONATE USE;
CONJUNCTIVITIS;
CZECH REPUBLIC;
DISEASE COURSE;
DISEASE SEVERITY;
ENZYME REPLACEMENT;
FATIGUE;
HUMAN;
HYDROCEPHALUS;
HYPOTENSION;
JOINT CONTRACTURE;
JOINT STIFFNESS;
LETTER;
LITHUANIA;
MAROTEAUX LAMY SYNDROME;
NARCOLEPSY;
PNEUMONIA;
POLAND;
PRIORITY JOURNAL;
RECURRENT INFECTION;
RESPIRATORY TRACT INFECTION;
SINUSITIS;
SPLENOMEGALY;
TACHYCARDIA;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
ENZYME REPLACEMENT THERAPY;
HUNTER SYNDROME;
MAROTEAUX-LAMY SYNDROME;
MUCOPOLYSACCHARIDOSIS TYPE II;
MUCOPOLYSACCHRIDOSIS TYPE VI;
ADOLESCENT;
CHILD;
DISEASE PROGRESSION;
DRUG ADMINISTRATION SCHEDULE;
ENZYME REPLACEMENT THERAPY;
EUROPE, EASTERN;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MUCOPOLYSACCHARIDOSES;
N-ACETYLGALACTOSAMINE-4-SULFATASE;
RECOMBINANT PROTEINS;
WITHHOLDING TREATMENT;
|
EID: 84893706920
PISSN: 10967192
EISSN: 10967206
Source Type: Journal
DOI: 10.1016/j.ymgme.2013.08.019 Document Type: Letter |
Times cited : (15)
|
References (3)
|